secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vicapsys Life Sciences, Inc. (VICP)
CIK:        0001468639
Form:       8-K
Filed at:   2023-01-12T23:59:59+00:00
Accession:  0001493152-23-001296
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vicapsys Life Sciences enters CEO employment agreement with $250k base salary, performance-based equity
--------------------------------------------------------------------------------

- CEO Federico Pier receives $250k annual base salary, subject to annual increase by Board.
- Eligible for annual cash bonus up to 100% of base salary based on performance objectives.
- One-time $100k cash bonus if common stock listed on NASDAQ/NYSE or company secures $8M+ financing.
- Equity awards: 1% of fully diluted shares at $250M market cap; additional 1% at $500M market cap.
- Agreement has five-year term with automatic yearly renewal; severance includes 12 months base salary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468639/000149315223001296/0001493152-23-001296-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468639/000149315223001296/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-001296

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer